This question is especially relevant for individuals who may not be classified as obese but are looking for weight management solutions
The translational potential of these platforms is reinforced by the clinical advancement of lipid nanoparticle (LNP) technologies, several of which have progressed to human trials for indications such as hypercholesterolemia, through PCSK9 silencing, and infectious diseases, including COVID-19 vaccines [429, 430]
BG has received fees for the activities of speaking, scientific advising, or clinical research from Eli Lilly, Novo Nordisk, AstraZeneca, Sanofi, Bristol Myers Squibb, Novartis, GlaxoSmithKline, Johnson & Johnson, Bayer, Intercept Pharma France, Gilead, Boehringer Ingelheim, Janssen, Intarcia, MetaCure, Pfizer, Merck Sharp & Dohme, Roche Diagnostics, Medtronic, Insulet, A
Before Wegovys launch, the number of providers with at least one written GLP-1 prescription remained relatively stable